Epigenetic therapy with hydralazine and magnesium valproate reverses imatinib resistance in patients with chronic myeloid leukemia

Eduardo Cervera, Myrna Candelaria, Omar López-Navarro, Juan Labardini, Aurora Gonzalez-Fierro, Lucia Taja-Chayeb, Jorge Cortes, Daniela Gordillo-Bastidas, Alfonso Dueñas-González

Research output: Contribution to journal › Article › peer-review